GLOBUS MEDICAL INC - A (GMED:NYSE)
$78.84 2.53 (3.3154%)
Analysed GLOBUS MEDICAL INC - A (GMED:NYSE) News Sources
Is it Apt to Retain Haemonetics Stock in Your Portfolio for Now?
15-10-2026
yahoo.com
Is it Apt to Retain Prestige Consumer Stock in Your Portfolio Now?
15-10-2026
yahoo.com
Doximity Deepens U.S. News Alliance to Improve Patient Access to Care
15-10-2026
yahoo.com
BD's Revello Stent Shows Strong AGILITY Trial Results for PAD Patients
15-10-2026
yahoo.com
Is it Apt to Retain Medtronic Stock in Your Portfolio Now?
16-10-2026
yahoo.com
Globus Medical to Showcase SCRIPT™ Patient-Specific Implants and New XLIF™ Prone Procedural Solution at NASS 2026
14-10-2026
yahoo.com
Globus Medical (GMED) Stock Looks Discounted Against Its Earnings Outlook
15-10-2026
yahoo.com
What Does Globus Medical (GMED) Mean For Spine Care After Its NASS 2026 Reveal?
15-10-2026
yahoo.com
Is Globus Medical (GMED) Cheap On Its Spine Platform Reveal?
15-10-2026
yahoo.com
Is Spine Tech Unveiling Altering The Investment Case For Globus Medical Stock?
16-10-2026
yahoo.com
What is the current price of GLOBUS MEDICAL INC - A (GMED:NYSE)?
The current price of GLOBUS MEDICAL INC - A (GMED:NYSE) is $78.84.
GLOBUS MEDICAL INC - A (GMED:NYSE) absolute price change since previous trading day?
The absolute price change of GLOBUS MEDICAL INC - A (GMED:NYSE) since the previous trading day is $2.53.
GLOBUS MEDICAL INC - A (GMED:NYSE) percentage price change since previous trading day?
The percentage price change of GLOBUS MEDICAL INC - A (GMED:NYSE) since the previous trading day is 3.3154%.
What is the most recent average sentiment score for GLOBUS MEDICAL INC - A (GMED:NYSE)?
The most recent average sentiment score for GLOBUS MEDICAL INC - A (GMED:NYSE) is 77 out of 100.
What is the most recent average sentiment for GLOBUS MEDICAL INC - A (GMED:NYSE)?
The most recent sentiment for GLOBUS MEDICAL INC - A (GMED:NYSE) is .
SEC-8K** Filing Available For GLOBUS MEDICAL INC - A (GMED:NYSE)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.